Richard Gabriel Muruve, 10% holder & director of Arch Biopartners Inc. (TSXV:ARCH), sold 118,000 Common Shares on the open market at an average of $0.85, a $100K sale on Sep 30, 2026, disclosed Oct 5, 2026.
The sale reduced the direct holding by about 1.2%. Muruve now holds 8,807,350 shares directly, worth about $7.3M at the Oct 5, 2026 close.
ARCH closed at $0.83 on Oct 5, 2026, up 5.1% over the prior three months. In the 52 weeks to that date it closed between $0.41 and $1.45, and that close was 43% below the high.
